Therapeutic effect of cimetidine in patients undergoing haemodialysis.
- 10 March 1979
- Vol. 1 (6164), 650-652
- https://doi.org/10.1136/bmj.1.6164.650
Abstract
Blood concentrations of cimetidine were measured and the therapeutic effect of the drug assessed patients undergoing maintenance haemodialysis. Thirteen patients were given a single oral 200-mg dose of cimetidine a mean of 2.7 hours before the start of dialysis. Dialysing for 6--12-6 m2 hours led to a mean fall of 71% in blood cimetidine concentration during haemodialysis. Nine patients with various upper gastrointestinal lesions diagnosed endoscopically were treated for up to six weeks with a reduced cimetidine dose of 200 mg 12-hourly; two patients received two courses of treatment. Repeat endoscopy after treatment disclosed satisfactory healing, and the drug did not accumulate. This lower dose regimen is recommended for patients receiving dialysis who develop upper gastrointestinal lesions for which a histamine H2-receptor antagonist is indicated.Keywords
This publication has 22 references indexed in Scilit:
- Cimetidine for duodenal ulceration in patients undergoing haemodialysis.BMJ, 1977
- Peptic ulceration, gastric secretion, and renal transplantation.BMJ, 1977
- REACTIONS TO CIMETIDINEThe Lancet, 1977
- H2-RECEPTOR ANTAGONISTS AND ANTACIDS IN THE PREVENTION OF ACUTE GASTROINTESTINAL HÆMORRHAGE IN FULMINANT HEPATIC FAILUREThe Lancet, 1977
- ORAL CIMETIDINE IN SEVERE DUODENAL ULCERATIONThe Lancet, 1977
- CIMETIDINE IN THE TREATMENT OF ACTIVE DUODENAL AND PREPYLORIC ULCERSThe Lancet, 1976
- Stress and the acute gastric mucosal lesionDigestive Diseases and Sciences, 1976
- PEPTIC ULCERATION IN CHRONIC RENAL FAILUREThe Lancet, 1973
- Effect of nephrectomy on the rate and pattern of the disappearance of exogenous gastrin in dogsGut, 1973
- GASTRIC ASSESSMENT OF PROSPECTIVE RENAL-TRANSPLANT PATIENTSThe Lancet, 1972